Literature DB >> 36083531

Retrospective analysis of an intensive medical weight loss program in adults with obesity and severe or end-stage chronic kidney disease.

Jingyi Cheng1, Brendan J Nolan2,3, Priya Sumithran4,5.   

Abstract

Entities:  

Keywords:  Chronic kidney disease; Obesity pharmacotherapy; Very low energy diet; Weight loss

Mesh：

Year:  2022        PMID： 36083531     DOI： 10.1007/s40620-022-01445-3

Source DB:  PubMed          Journal:  J Nephrol        ISSN： 1121-8428            Impact factor:   4.393


× No keyword cloud information.
  4 in total

Review 1.  The application of body mass index-based eligibility criteria may represent an unjustified barrier to renal transplantation in people with obesity.

Authors:  Alanna Tan; Scott Wilson; Priya Sumithran
Journal:  Clin Obes       Date:  2021-12-28

2.  Safety and Efficacy of Liraglutide in Patients With Type 2 Diabetes and End-Stage Renal Disease: An Investigator-Initiated, Placebo-Controlled, Double-Blind, Parallel-Group, Randomized Trial.

Authors:  Thomas Idorn; Filip K Knop; Morten B Jørgensen; Tonny Jensen; Marsela Resuli; Pernille M Hansen; Karl B Christensen; Jens J Holst; Mads Hornum; Bo Feldt-Rasmussen
Journal:  Diabetes Care       Date:  2015-08-17       Impact factor: 19.112

Review 3.  Bariatric surgery for the treatment of chronic kidney disease in obesity and type 2 diabetes mellitus.

Authors:  Neil G Docherty; Carel W le Roux
Journal:  Nat Rev Nephrol       Date:  2020-08-10       Impact factor: 28.314

4.  Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes.

Authors:  Rena R Wing; Wei Lang; Thomas A Wadden; Monika Safford; William C Knowler; Alain G Bertoni; James O Hill; Frederick L Brancati; Anne Peters; Lynne Wagenknecht
Journal:  Diabetes Care       Date:  2011-05-18       Impact factor: 19.112
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.